Bendera Anderson, Baryomuntebe Deogratias Mugisha, Kevin Nwanna Uchechukwu, Nanyingi Miisa, Kinengyere Patience Bemanya, Mujeeb Salaam, Sulle Esther Jachi
Department of Radiology and Medical Imaging, Monduli District Hospital, Arusha, Tanzania.
Faculty of Nursing, Fins Medical University, Kampala, Uganda.
HIV AIDS (Auckl). 2024 Aug 26;16:313-323. doi: 10.2147/HIV.S473291. eCollection 2024.
About half of people infected with Human Immunodeficiency Virus (HIV) often present late for care, resulting in higher healthcare costs, undesired treatment outcomes, and ongoing HIV transmission. This study aimed to assess the prevalence and determinants of late HIV diagnosis and advanced HIV disease (AHD) in Tanzania.
Data were obtained from the 2016-17 Tanzania HIV impact survey. We included 677 newly diagnosed people living with HIV. Late HIV diagnosis and AHD were defined as having a CD4 cell count below 350 cells/µL or 200 cells/µL at diagnosis, respectively. Bivariate and multivariable logistic regression models were fitted to identify the determinants of late HIV diagnosis or AHD.
The mean age of the participants was 37.8 years (SD, 12.4). About two-thirds were women (62.6%). The prevalence of late HIV diagnosis was 42.4%, whereas the prevalence of AHD was 17.7%. Factors associated with late HIV diagnosis included age 31-40 years (adjusted odds ratio [aOR] = 1.72, 95% confidence interval [CI]: 1.14-2.60), age ≥41 years (aOR = 1.79, 95% CI: 1.16-2.76), male sex (aOR = 1.88, 95% CI: 1.29-2.73), and active syphilis infection (aOR=2.63, 95% CI: 1.20-5.76). Factors associated with AHD were age 31-40 years (aOR = 2.12, 95% CI: 1.18-3.81), age ≥41 years (aOR = 2.42, 95% CI: 1.32-4.41), male sex (aOR = 1.77, 95% CI: 1.09-2.87), formal education (aOR = 0.49, 95% CI: 0.30-0.81) and active syphilis infection (aOR = 2.49, 95% CI: 1.07-5.77).
Late HIV diagnosis and AHD are prevalent among newly diagnosed people living with HIV in Tanzania. Specific subgroups are more likely to present late for HIV care, including middle-aged and older adults, men, illiterate individuals, and those with active syphilis and HIV co-infection. Therefore, we recommend expanding HIV testing services and implementing targeted interventions to improve early access and enrollment in HIV care.
约一半感染人类免疫缺陷病毒(HIV)的人往往就医延迟,这导致更高的医疗成本、不理想的治疗结果以及持续的HIV传播。本研究旨在评估坦桑尼亚HIV诊断延迟和晚期HIV疾病(AHD)的患病率及决定因素。
数据来自2016 - 17年坦桑尼亚HIV影响调查。我们纳入了677名新诊断的HIV感染者。HIV诊断延迟和AHD分别定义为诊断时CD4细胞计数低于350个/微升或200个/微升。采用双变量和多变量逻辑回归模型来确定HIV诊断延迟或AHD的决定因素。
参与者的平均年龄为37.8岁(标准差,12.4)。约三分之二为女性(62.6%)。HIV诊断延迟的患病率为42.4%,而AHD的患病率为17.7%。与HIV诊断延迟相关的因素包括31 - 40岁(调整后的优势比[aOR]=1.72,95%置信区间[CI]:1.14 - 2.60)、年龄≥41岁(aOR = 1.79,95% CI:1.16 - 2.76)、男性(aOR = 1.88,95% CI:1.29 - 2.73)以及活动性梅毒感染(aOR = 2.63,95% CI:1.20 - 5.76)。与AHD相关的因素包括31 - 40岁(aOR = 2.12,95% CI:1.18 - 3.81)、年龄≥41岁(aOR = 2.42,95% CI:1.32 - 4.41)、男性(aOR = 1.77,95% CI:1.09 - 2.87)、正规教育(aOR = 0.49,95% CI:0.30 - 0.81)以及活动性梅毒感染(aOR = 2.49,95% CI:1.07 - 5.77)。
在坦桑尼亚新诊断的HIV感染者中,HIV诊断延迟和AHD很普遍。特定亚组更有可能就医延迟接受HIV治疗,包括中年及老年成年人、男性、文盲个体以及患有活动性梅毒和HIV合并感染的人。因此,我们建议扩大HIV检测服务并实施有针对性的干预措施,以改善早期获得HIV治疗并提高其登记率。